L. Ferraro et al., Amplification of cortical serotonin release: a further neurochemical action of the vigilance-promoting drug modafinil, NEUROPHARM, 39(11), 2000, pp. 1974-1983
The present in vitro and in vivo studies examined the effects of modafinil
on serotonergic transmission in the rat frontal cortex. In the in vitro stu
dy modafinil (0.3-30 mu M) increased electrically-evoked, but not spontaneo
us, serotonin ([H-3]5-HT) efflux from cortical slices in a concentration-de
pendent manner while the indirect serotonin agonist dl-fenfluramine (1-15 m
u M) enhanced both spontaneous and evoked [3H]5-HT efflux. The effects of m
odafinil were more pronounced when the 5-HT reuptake was blocked by paroxet
ine. Contrary to paroxetine (0.3-3 mu M) and dl-fenfluramine (1-5 mu M), mo
dafinil failed to influence the [H-3]5-HT uptake. In the in vivo study moda
finil (3-100 mg/kg i.p.) increased 5-HT dialysate levels, the maximal effec
t being already reached at the 30 mg/kg dose. dl-fenfluramine (5 mg/kg) ind
uced an increase in 5-HT levels which was significantly higher than that di
splayed by modafinil at 30 mg/kg. In the presence of paroxetine (3 mu M), t
he effect of modafinil at 30 mg/kg was higher than that observed in the abs
ence of 5-HT reuptake inhibition. Finally, in the presence of the selective
5-NT1A receptor agonist 8-OH-DPAT, modafinil at 100 mg/kg failed to affect
5-HT dialysate levels.
These results demonstrate that modafinil regulates cortical serotonergic tr
ansmission and suggest that the drug preferentially acts by amplifying the
electro-neurosecretory coupling mechanisms and via mechanisms which do not
involve the reuptake process. (C) 2000 Elsevier Science Ltd. All rights res
erved.